连日来,药明生物(2269.HK)动作不断。 1月6日晚间,药明生物发布公告表示,其间接全资附属公司药明海德爱尔兰(WuXi Vaccines Ireland Limited)将向默沙东出售与爱尔兰疫苗设施相关的资产,交易总对价约为5亿美元。 “爱尔兰疫苗设施是药明海德爱尔兰为默沙东生产商业疫苗产品而专门设计及建造的。”公告显示,“此次资产交易不仅为公司带来了现金流,还能提升公司的资产效率及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.